Luke Riggan is an associate at Amplify Partners, investing in digital biology. He previously co-founded ImmunoVec, where he helped lead gene therapy development, and invested in therapeutics as a venture partner at EGB Capital.
Luke Riggan is an associate at Amplify Partners, investing in digital biology. He previously co-founded ImmunoVec, where he helped lead gene therapy development, and invested in therapeutics as a venture partner at EGB Capital.